Segment Information (Tables)

9 Months Ended

Sep. 30, 2013

Segment Information [Abstract]

Segment Financial Information

The following tables present operating group financial information for the periods indicated:

	Three Months Ended September 30, 2013								Nine Months Ended September 30, 2013
	Healthcare		DNA			Total			Healthcare		DNA			Total
Net sales:
Software and other	$	11,291	$	8,066		$	19,357		$	43,243	$	17,564		$	60,807
Professional Services		6,335		4,112			10,447			21,580		12,542			34,122
Maintenance and EDI		26,872		569			27,441			81,523		1,620			83,143
Total net sales	$	44,498	$	12,747		$	57,245		$	146,346	$	31,726		$	178,072
Expenses		42,995		9,847			52,842			131,798		28,085			159,883
Segment income (loss)	$	1,503	$	2,900			4,403		$	14,548	$	3,641			18,189
Net corporate/other expenses (1)							8,982								53,658
Loss before income taxes						$	(4,579	)						$	(35,469	)
	Three Months Ended September 30, 2012								Nine Months Ended September 30, 2012
	Healthcare		DNA			Total			Healthcare		DNA			Total
Net sales:
Software and other	$	17,854	$	3,378		$	21,232		$	56,911	$	12,340		$	69,251
Professional Services		7,808		3,469			11,277			20,873		9,700			30,573
Maintenance and EDI		27,158		727			27,885			82,694		1,740			84,434
Total net sales	$	52,820	$	7,574		$	60,394		$	160,478	$	23,780		$	184,258
Expenses		43,447		8,746			52,193			131,675		25,643			157,318
Segment income (loss)	$	9,373	$	(1,172	)		8,201		$	28,803	$	(1,863	)		26,940
Net corporate/other expenses (1)							10,343								35,098
Loss before income taxes						$	(2,142	)						$	(8,158	)
		(1) Net corporate/other expenses include public company costs, corporate administration expenses, amortization expense which is not attributable to business segments, acquisition-related expenses and net interest expense.

	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Three Months Ended September 30, 2013	$	3,395	$	1,051	$	10		$	4,456
Nine Months Ended September 30, 2013		10,137		3,146		41			13,324
Restructuring and Other One Time Charges
Three Months Ended September 30, 2013		1,366		123		565			2,054
Nine Months Ended September 30, 2013		2,886		405		565			3,856
Assets as of September 30, 2013	$	417,399	$	40,221	$	(63,803	)	$	393,817
	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Three Months Ended September 30, 2012	$	3,621	$	1,063	$	16		$	4,700
Nine Months Ended September 30, 2012		11,128		2,841		43			14,012
Restructuring and Other One Time Charges
Three Months Ended September 30, 2012		333		497		-			830
Nine Months Ended September 30, 2012		333		497		-			830
Assets as of December 31, 2012	$	412,841	$	33,207	$	(9,195	)	$	436,853